Sun Pharma Recalls 10 Eye Drops Amid Contamination Fears

Sun Pharma has initiated a recall of 10 of its eye drop products across India due to potential contamination concerns. The company issued a confidential letter on July 17, instructing distributors to immediately stop selling existing batches of these specific eye drops and return any remaining stock. This action is described as a precautionary measure to ensure patient safety.

A spokesperson for Sun Pharma emphasized that patient safety is the company's top priority and that all necessary steps are being taken in compliance with regulatory requirements. The company is working diligently to make these products available again, ensuring patients can continue their treatment options.

These recalled eye drops are often prescribed for individuals recovering from eye surgery or managing chronic conditions such as glaucoma, eye infections, and ocular inflammation. Experts warn that disrupting treatment for these conditions can lead to significant negative outcomes, highlighting the critical need for sterile manufacturing and prompt action in such cases.